Skip to search formSkip to main contentSkip to account menu

melanoma helper peptide vaccine

Known as: MHP VAC 
A multivalent vaccine consisting of peptides derived from melanoma-associated antigens and an adjuvant peptide derived from tetanus toxoid… 
National Institutes of Health

Related topics

Related topics

1 relation
melanoma helper peptide vaccine/Montanide ISA-51/multi-epitope melanoma peptide vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes
Background Cancers produce soluble and cell-associated molecules that can suppress or alter antitumor immunity. Preclinical… 
2012
2012
The impact of a multi-epitope melanoma helper peptide vaccine on Th1 cytokine production by responding lymphocytes.
e19028 Background: Melanomas produce soluble and cell-associated molecules that can suppress or alter antitumor immunity… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)